UHS Universal Health Services, Inc. Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 8월 7, 2026UHS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
UHS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2009년 12월 16일 | 2-for-1 | 정방향 |
| 2001년 6월 4일 | 2-for-1 | 정방향 |
| 1996년 5월 20일 | 2-for-1 | 정방향 |
| 1983년 7월 5일 | 2-for-1 | 정방향 |
Universal Health Services, Inc. Common Stock 정보 위키백과 회사 개요
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Company history
Alan B. Miller, who currently serves as the company's Executive Chairman, founded Universal Health Services, Inc. in 1979. Within 18 months of its founding, UHS owned four hospitals and had management contracts with two additional hospitals.
In 1979, UHS entered Las Vegas with the purchase of Valley Hospital.
In 1980, the company chose its first Board of Directors. In 1981, UHS held its initial public offering. In 1982, UHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation purchased hospitals from a nonprofit religious organization. In 1983, UHS purchased Qualicare, Inc. for more than $116 million. The purchase included 11 acute care hospitals and four behavioral health hospitals. In 1986, UHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry.
In 1991, UHS stock trading moved from NASDAQ to NYSE.
In November 2010, UHS reached an agreement in May to acquire Psychiatric Solutions, Inc. for $3.1 billion. In June 2012, UHS announced its plans to acquire Ascend Health Corporation for $517 million. In February 2014, UHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde Behavioral Health. In April of that year, UHS announced the acquisition of the Psychiatric Institute of Washington. In September of that year, UHS' stock joined the S&P 500 Index and acquired Cygnet Health Care Limited for approximately $335 million. In August 2015, UHS acquired Alpha Hospitals Holdings Limited for $148 million from private equity group C&C Alpha Group. In September of that year, UHS announced the acquisition of Foundations Recovery Network based in Brentwood, Tennessee for $350 million. In August 2016, UHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount. In December of that year, UHS acquired Cambian Group PLC's Adult Services Division. In July 2018, UHS announced its acquisition of the Danshell Group.
On September 28, 2020, Universal Health Services Inc. announced that its network went offline after an unspecified "IT security issue".
In September 2020, consistent with the company's long-standing succession plan, UHS announced that Alan B. Miller would step down as CEO in January 2021 and that President Marc D. Miller would be named CEO.
UHS ranked on the Fortune 500 in 2021, 2022 in 2023 and 2024, and 2025
UHS was named on the Fortune World's Most Admired List in 2025, 2024 2023, 2022, 2021 and 2020.
UHS has been named on the Forbes Global 2000 ranking in 2025. UHS is ranked at #1,090. Of the American companies on the ranking, UHS ranked #355 among U.S. companies and #23 among global Health Care Equipment and Services category. UHS has been on the ranking for 22 years, and in 2023 earned ‘Hall of Fame’ status.
In March 2026, UHS agreed to acquire online and mobile therapy service provider Talkspace for $835 million.
Controversies
Hospital licenses
The Centers for Medicare and Medicaid Services (CMS) threatened the Rancho Springs Medical Center (Murrieta) and Inland Valley Regional Medical Center (Wildomar) in California with decertification in June 2010 while the State of California warned of a possible hospital license revocation. Universal Health Services implemented a program to address all concerns and in November 2011 the two hospitals passed a CMS Certification Survey. As a result, CMS rescinded its termination notice and the California Department of Public Health withdrew its license revocation notice.
Allegations of noncompliance with same-sex visitation law
According to a petition started on Change.org by Terri-Ann Simonelli of Henderson, Nevada, Spring Valley Hospital (owned and operated by UHS) claimed that their policy required power of attorney for a same-sex partner to make medical decisions on behalf of their partner. If true, this would seemingly violate new Department of Health and Human Services rules enabling same-sex partners to make said decisions, with or without power of attorney.
Fraudulent Medicaid claims
In September 2012, UHS and its subsidiaries, Keystone Education and Youth Services LLC and Keystone Marion LLC d/b/a Keystone Marion Youth Center agreed to pay over $6.9 million to resolve allegations that they submitted false and fraudulent claims to Medicaid. Between October 2004 and March 2010, the entities allegedly provided substandard psychiatric counseling and treatment to adolescents in violation of the Medicaid requirements. The United States alleged that UHS falsely represented Keystone Marion Youth Center as a residential treatment facility providing inpatient psychiatric services to Medicaid enrolled children, when in fact it was a juvenile detention facility. The United States further alleged that neither a medical director nor licensed psychiatrist provided the required direction for psychiatric services or for the development of initial or continuing treatment plans. The settlement further resolved allegations that the entities filed false records or statements to Medicaid when they filed treatment plans that falsely represented the level of services that would be provided to the patients.
On July 10, 2020, the US Department of Justice announced a $122 million Fraudulent Claims case with "Universal Health Services, Inc., UHS of Delaware, Inc.(together, UHS), and Turning Point Care Center, LLC (Turning Point), a UHS facility located in Moultrie, Georgia, have agreed to pay a combined total of $122 million to resolve alleged violations of the False Claims Act for billing for medically unnecessary inpatient behavioral health services, failing to provide adequate and appropriate services, and paying illegal inducements to federal healthcare beneficiaries." From the announcement: "The government alleged that, between January 2006, and December 2018, UHS's facilities admitted federal healthcare beneficiaries who were not eligible for inpatient or residential treatment because their conditions did not require that level of care, while also failing to properly discharge appropriately admitted beneficiaries when they no longer required inpatient care. The government further alleged that UHS's facilities billed for services not rendered, billed for improper and excessive lengths of stay, failed to provide adequate staffing, training, and/or supervision of staff, and improperly used physical and chemical restraints and seclusion. In addition, UHS's facilities allegedly failed to develop and/or update individual assessments and treatment plans for patients, failed to provide adequate discharge planning, and failed to provide required individual and group therapy services in accordance with federal and state regulations.
Of the $117 million to be paid by UHS to resolve these claims, the federal government will receive a total of $88,124,761.27, and a total of $28,875,238.73 will be returned to individual states, which jointly fund state Medicaid programs."
BuzzFeed investigation
On December 7, 2016, BuzzFeed published a report detailing questionable practices within UHS psychiatric facilities. The report includes allegations of holding nonthreatening patients against their will, manipulative misinterpretation of patient testimonies to fit guidelines to involuntary confinement, aggressive staff layoffs and understaffing in hospitals, needless patient deaths due to understaffing and misprescription of medication, "violating a patient's right to be discharged or holding a patient without the proper documentation", and unnecessary extension of stay times to the maximum Medicare payout. UHS denied the conclusions of the report. UHS stock fell approximately 12% after publication.
According to BuzzFeed investigative reporter Rosalind Adams, UHS responded to the report by hiring "a global PR firm that offers specialized crisis management services... UHS didn't just implement a crisis PR plan. It also fired an employee that the company believed to have spoken to a reporter; it sued a former employee it alleges leaked damaging internal surveillance videos; it threatened to sue other employees; at least one facility held a series of town hall meetings to warn employees from speaking with us; it conducted "in-depth interviews" with nearly two dozen staff, then distributed a public apology that two of them signed; it enlisted one of the most powerful law firms in the United States; it built multiple, high-production-value websites specifically designed to overcome the reputational damage that our reporting might cause."
Cygnet Healthcare
A UK subsidiary, Cygnet Health Care, was the subject of a BBC investigation that found that staff had been taunting, provoking and scaring vulnerable people. It runs 140 mental health services across the UK. 85% of its services are "rated good or outstanding by our regulators". New admissions were banned at Cygnet Acer clinic after the Care Quality Commission found it unsafe to use. A patient hanged herself, others self harmed, ligature points were found where patients could hang themselves and too many of the staff were untrained to deal with the highly vulnerable patients at the clinic.
The company bought four inpatient units which were previously operated by the Danshell Group in 2018. All four were condemned by the Care Quality Commission which raised concerns about patients' "unexplained injuries" and high levels of restraint in 2019.
Laurel Oaks Behavior Health Center
On February 8, 2024, a lawsuit was filed against the company's Dothan, Alabama-based Laurel Oaks Behavioral Health Center and its CEO Janette Jackson which alleged that Laurel Oaks Behavior Health Center mishandled numerous incidents involving the assault of an eight-year-old boy residing in the facility. The boy was reportedly assaulted by his larger roommate while he residing at the facility for a week in 2022. Universal Health Services would be sued as well. The lawsuit also noted that a 40-year-old man was convicted in 2011 of sexually assaulting a teenage patient while employed at Laurel Oaks. A 17-year-old patient had been charged in 2014 with felony counts of first-degree sodomy as well.
Provo Canyon School
Provo Canyon School was the name two residential treatment centers operated by UHS before being shutdown by the Utah DHHS. The school was in media headlines for years as abuse was prominent throughout its history, including past owners. To name a few allegations, "using a cruel, unusual, or unnecessary practice on a child by withholding personal interaction, emotional response, or stimulation", and "depriving [children] (cilents) of water, rest, and the opportunity for toileting."
Additional allegations
On May 16, 2021, Detroit Free Press published an article alleging UHS partner St. Simons By The Sea (formerly Focus By The Sea) in St. Simons Island, Georgia recruited patients from a local soup kitchen for treatment that may have been coercive or medically unnecessary.(subscription required)
Facilities
Hospitals and medical centers
As of June 2024, the UCS website lists the following medical and acute care facilities in the United States.
California
Corona
Southwest Healthcare Corona Regional Medical Center
Murrieta
A Plus Urgent Care
Southwest Healthcare Rancho Springs Hospital
Temecula Valley Day Surgery
Palmdale
Southwest Healthcare Palmdale Regional Medical Center
Riverside
Riverside Medical Clinic
Temecula
Southwest Healthcare Temecula Valley Hospital
Wildomar
Southwest Healthcare Inland Valley Hospital
District of Columbia
Washington
The George Washington University Hospital
Cedar Hill Hospital Medical Center
Florida
Arcadia
Manatee Diagnostic Center (Arcadia)
Bradenton
ER at Bayshore Gardens
ER at Sun City Center
ER at Palma Sola
Lakewood Ranch Medical Center
Lakewood Ranch Medical Group
Manatee Diagnostic Center (Pointe West)
Manatee Diagnostic Center (Riverside)
Manatee Health
Manatee Memorial Hospital
Manatee Physician Alliance
Orlando
University Behaviorial Center
Parrish
Manatee Diagnostic Center (Parrish)
Royal Palm Beach
Palms Westside Clinic ASC
Sarasota
ER at Fruitville
Wellington
Wellington Physicians Alliance
West Palm Beach
Wellington Regional Medical Center
Westlake
ER at Westlake
Wimauma
ER at Sun City Center
Nevada
Henderson
ER at Green Valley Ranch
Henderson Hospital
Las Vegas
Centennial Hills Hospital Medical Center
Elite Medical Center
ER at Blue Diamond
ER at Desert Springs
ER at West Craig Road
Spring Valley Hospital Medical Center
Summerlin Hospital Medical Center
Valley Health Physician Alliance
Valley Health Specialty Hospital
Valley Hospital Medical Center
North Las Vegas
ER at North Las Vegas
ER at Valley Vista
Pahrump
Desert View Hospital
Reno
ER at Damonte Ranch
ER at McCarran NW
Northern Nevada Sierra Medical Center
Quail Surgical and Pain Management Center
Sparks
ER at Spanish Springs
Northern Nevada Medical Center
Northern Nevada Medical Group
Oklahoma
Enid
St. Mary's Physician Associates
St. Mary's Regional Medical Center
Pennsylvania
King of Prussia
Eastern Pennsylvania Physician Alliance
UHS Corporate
South Carolina
Aiken
Aiken Physicians Alliance
Aiken Regional Medical Centers
Cancer Care Institute of Carolina
The Surgery Center of Aiken
North Augusta
ER at Sweetwater
Texas
Alamo
South Texas Health System ER Alamo
Amarillo
Northwest Emergency at Town Square
Northwest Emergency on Georgia
Northwest Physicians Group
Northwest Texas Healthcare System
Anna
ER at Anna
Bonham
TMC Bonham Hospital
Denison
Texoma Medical Center
TexomaCare
Eagle Pass
Fort Duncan Regional Medical Center
Edinburg
Cornerstone Regional Hospital
South Texas Health System Edinburg / South Texas Health System Children's
South Texas Health System ER McColl
South Texas Health System ER Monte Cristo
Laredo
Doctors Hospital Emergency Room Saunders
Doctors Hospital Emergency Room South
Doctors Hospital of Laredo
Laredo Physicians Group
McAllen
South Texas Health System Clinics
South Texas Health System ER Ware Road
South Texas Health System Heart
South Texas Health System McAllen
Mission
South Texas Health System ER Mission
Sherman
ER at Sherman
Weslaco
South Texas Health System ER Weslaco
Behavioral health facilities
UHS also operates over 300 behavioral health facilities in the United States and the United Kingdom, including:
Cygnet Health Care, UK
Psychiatric Institute of Washington, Washington, District of Columbia
Suncoast Behavioral Health Center, Bradenton, Florida
Fuller Hospital, South Attleboro, Massachusetts
Willow Springs Center, Reno, Nevada
Friends Hospital, Philadelphia, Pennsylvania
Provo Canyon School, Provo, Utah
Lancaster Behavioral Health Hospital, Lancaster, PA
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | UHS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | 7.25년 평균 ≈11.7 | ≈11.7 | 16.5 | 저평가 | |
| PEG Ratio (PEG 비율) | ≈0.4 | · | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | UHS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 영업이익률 (TTM) | 11.4%5년 평균 ≈10.1% | ≈10.1% | 11.9% | 약함 | |
| EBITDA Margin (EBITDA 마진) | 11.5%5년 평균 ≈10.1% | ≈10.1% | 11.1% | 동일 | |
| 세전 마진 (TTM) | 11.2%5년 평균 ≈9.1% | ≈9.1% | 9.8% | 동일 | |
| 순이익률 (TTM) | 8.4%5년 평균 ≈6.9% | ≈6.9% | 7.3% | 동일 | |
| ROA (TTM) | 9.9%5년 평균 ≈7.7% | ≈7.7% | 6.5% | 최상위권 | |
| ROE (TTM) | 21.0%5년 평균 ≈17.0% | ≈17.0% | 19.1% | 동일 | |
| ROIC | 12.7%5년 평균 ≈10.8% | ≈10.8% | 13.5% | 약함 |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | UHS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 (MRQ) | 0.65년 평균 ≈0.7 | ≈0.7 | 0.2 | 높은 부채 | |
| 유동비율 (MRQ) | 1.15년 평균 ≈1.2 | ≈1.2 | 1.2 | 낮은 유동성 | |
| Quick Ratio (당좌 비율) | 0.85년 평균 ≈1.0 | ≈1.0 | 0.9 | 동일 | |
| 장기 부채 / 자기 자본 (MRQ) | 0.55년 평균 ≈0.7 | ≈0.7 | 0.2 | 높은 부채 | |
| Interest Coverage (이자 보상 배율) | 12.85년 평균 ≈9.2 | ≈9.2 | 7.8 | 강한 유동성 |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | UHS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | 9.7%5년 평균 ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | 9.0%5년 평균 ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 8.5% | · | · | · | |
| EPS YoY | 37.3%5년 평균 ≈37.9% | ≈37.9% | · | · | |
| Net Income YoY (순이익 YoY) | 30.4%5년 평균 ≈31.9% | ≈31.9% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3년) | 36.2%5년 평균 ≈15.4% | ≈15.4% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5년) | 16.0% | · | · | · | |
| Net Income CAGR 3Y (순이익 CAGR 3년) | 30.1%5년 평균 ≈8.7% | ≈8.7% | · | · | |
| Net Income CAGR 5Y (순이익 CAGR 5년) | 9.5% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | UHS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 1.25년 평균 ≈1.1 | ≈1.1 | 0.8 | 최상위권 | |
| Receivables Turnover (매출 채권 회전율) | 7.35년 평균 ≈7.0 | ≈7.0 | 8.4 | 약함 | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$170.2K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
| 배당락일 | 금액 | 통화 | 수익률 |
|---|---|---|---|
| 9월 1, 2026 | $0.20 | USD | ≈0.47% |
| 6월 8, 2026 | $0.20 | USD | ≈0.56% |
| 3월 2, 2026 | $0.20 | USD | ≈0.39% |
| 12월 1, 2025 | $0.20 | USD | ≈0.33% |
| 9월 2, 2025 | $0.20 | USD | ≈0.44% |
| 6월 2, 2025 | $0.20 | USD | ≈0.43% |
| 3월 3, 2025 | $0.20 | USD | ≈0.46% |
| 12월 3, 2024 | $0.20 | USD | ≈0.40% |
| 9월 3, 2024 | $0.20 | USD | ≈0.34% |
| 6월 3, 2024 | $0.20 | USD | ≈0.43% |
| 2월 29, 2024 | $0.20 | USD | ≈0.48% |
| 11월 30, 2023 | $0.20 | USD | ≈0.58% |
| 8월 31, 2023 | $0.20 | USD | ≈0.59% |
| 5월 31, 2023 | $0.20 | USD | ≈0.61% |
| 2월 28, 2023 | $0.20 | USD | ≈0.60% |
| 11월 30, 2022 | $0.20 | USD | ≈0.61% |
| 8월 31, 2022 | $0.20 | USD | ≈0.82% |
| 5월 31, 2022 | $0.20 | USD | ≈0.64% |
| 2월 28, 2022 | $0.20 | USD | ≈0.56% |
| 11월 30, 2021 | $0.20 | USD | ≈0.67% |
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 7월 27, 2026 | $5.98 | $6.02 | -0.61% |
| 2026년 3월 31일 | $5.62 | $5.46 | 2.9% | |
| 2025년 12월 31일 | $5.88 | $5.96 | -1.3% | |
| 2025년 9월 30일 | $5.69 | $4.88 | 16.5% | |
| 2025년 6월 30일 | $5.35 | $4.97 | 7.6% | |
| 2025년 3월 31일 | $4.84 | $4.39 | 10.2% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Operating Expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | |
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | |
| Interest Expense | $156M | $186M | $207M | $127M | $84M | $106M | $163M | $155M | $145M | $125M | $113M | $134M | |
| Other Non-op | $134M | $2M | $-28M | $-10M | $14M | $14.0K | $13M | $14M | $0 | $0 | · | · | |
| Pretax Income | $1.97B | $1.50B | $940M | $866M | $1.29B | $1.25B | $1.07B | $1.03B | $1.14B | $1.16B | $1.15B | $930M | |
| Income Tax | $461M | $335M | $221M | $209M | $306M | $299M | $239M | $237M | $364M | $409M | $395M | $325M | |
| Net Income | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | |
| Shares (Basic) | 63,581,000 | 66,554,000 | 69,321,000 | 73,118,000 | 82,519,000 | 85,061,000 | 88,762,000 | 93,276,000 | 95,652,000 | 97,208,000 | 98,797,000 | 98,826,000 | |
| Shares (Diluted) | 64,462,000 | 67,896,000 | 70,125,000 | 73,832,000 | 83,692,000 | 85,587,000 | 89,040,000 | 93,750,000 | 96,325,000 | 98,380,000 | 100,694,000 | 100,544,000 | |
| EBITDA | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.66B | $1.44B |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $126M | $119M | $103M | $115M | $1.22B | $61M | $105M | $74M | $34M | $61M | $32M | |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B | $1.73B | $1.56B | $1.51B | $1.50B | $1.44B | $1.30B | $1.28B | |
| Other Current Assets | $436M | $292M | $237M | $198M | $195M | $138M | $134M | $174M | $87M | $83M | $103M | $78M | |
| Current Assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B | $1.72B | $1.62B | |
| PP&E (Net) | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B | $5.37B | $5.02B | $4.85B | $4.57B | $4.33B | $3.84B | $3.68B | |
| PP&E (Gross) | $13.49B | $12.64B | $11.78B | $11.09B | $10.77B | $9.89B | $9.11B | $8.56B | $7.92B | $7.31B | $6.53B | $6.21B | |
| Accum. Depreciation | $6.48B | $6.07B | $5.65B | $5.17B | $4.90B | $4.51B | $4.09B | $3.72B | $3.35B | $2.98B | $2.69B | $2.53B | |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B | $3.88B | $3.87B | $3.84B | $3.83B | $3.78B | $3.60B | $3.29B | |
| Intangibles | $76M | $76M | $77M | $78M | $81M | $83M | $84M | $173M | $220M | $228M | $219M | $98M | |
| Other Non-current Assets | $5.11B | $5.08B | $5.03B | $5.04B | $4.96B | $4.82B | $4.74B | $4.48B | $4.39B | $4.31B | $4.06B | $3.68B | |
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.95B | |
| Accounts Payable | $750M | $632M | $614M | $637M | $659M | $571M | $447M | $446M | $442M | $440M | $366M | $336M | |
| Current Liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B | $2.48B | $1.56B | $1.45B | $1.85B | $1.32B | $1.10B | $1.18B | |
| Capital Leases | $341M | $376M | $383M | $396M | $305M | $278M | $270M | $18M | $20M | $22M | $23M | · | |
| Deferred Tax | $6M | $0 | · | · | $0 | $6M | $25M | $50M | $55M | $88M | $316M | $168M | |
| Other Non-current Liabilities | $528M | $656M | $584M | $488M | $465M | $459M | $330M | $362M | $306M | $275M | $279M | $269M | |
| Long-term Debt | $4.80B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.43B | $3.28B | |
| Total Debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.45B | $3.28B | |
| Retained Earnings | $7.99B | $7.37B | $6.80B | $6.53B | $6.60B | $6.75B | $5.93B | $5.79B | $5.35B | $4.89B | $4.57B | $4.02B | |
| AOCI | $48M | $7M | $9M | $-10M | $30M | $48M | $32M | $4M | $7M | $-25M | $-23M | $-25M | |
| Stockholders' Equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B | $4.25B | $3.74B | |
| Liabilities + Equity | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.97B |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619M | $585M | $568M | $582M | $533M | $510M | $490M | $453M | $448M | $417M | $399M | $376M | |
| Stock-based Comp | $96M | $99M | $88M | $85M | $74M | $66M | $69M | $67M | $57M | $48M | $40M | $31M | |
| Deferred Tax | $51M | $-33M | $-18M | $-18M | $-30M | $-27M | $-36M | $-10M | $-37M | $-10M | $-11M | $49M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | $-88M | $35M | |
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $996M | $884M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B | $1.07B | $1.04B | |
| CapEx | $1.02B | $944M | $743M | $734M | $856M | $731M | $634M | $665M | $558M | $520M | $379M | $391M | |
| Investing Cash Flow | $-1.07B | $-911M | $-763M | $-647M | $-914M | $-803M | $-688M | $-747M | $-685M | $-1.16B | $-913M | $-833M | |
| Net Debt Issued | $-44M | $-2.64B | $-85M | $-89M | $-3.04B | $-963M | $-57M | $-830M | $-143M | $-459M | $-68M | $-879M | |
| Stock Issued | $17M | $15M | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $10M | $8M | $7M | |
| Stock Repurchased | $968M | $671M | $547M | $833M | $1.22B | $207M | $771M | $397M | $364M | $353M | $210M | $101M | |
| Net Stock Activity | $-951M | $-656M | $-534M | $-819M | $-1.21B | $-194M | $-760M | $-387M | $-354M | $-344M | $-201M | $-94M | |
| Dividends Paid | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M | |
| Financing Cash Flow | $-750M | $-1.14B | $-494M | $-318M | $-1.07B | $-385M | $-845M | $-492M | $-519M | $-171M | $-125M | $-187M | |
| Net Change in Cash | $47M | $10M | $14M | $22M | $-1.10B | $1.17B | $-94M | $32M | $45M | $5M | $29M | $15M | |
| Taxes Paid | $471M | $325M | $258M | $251M | $363M | $286M | $261M | $294M | $371M | $345M | $381M | $259M | |
| Free Cash Flow | $849M | $1.12B | $525M | $262M | $28M | $1.63B | $804M | $676M | $625M | $769M | $642M | $645M | |
| Levered FCF | $730M | $979M | $367M | $166M | $-36M | $1.55B | $678M | $556M | $526M | $688M | $567M | $558M |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.2% | |
| Net Margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.8% | |
| Pretax Margin | 11.4% | 9.5% | 6.6% | 6.5% | 10.2% | 10.8% | 9.4% | 9.6% | 10.9% | 11.8% | 12.7% | 11.5% | |
| EBITDA Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 18.3% | 17.8% | |
| ROA | 9.9% | 8.0% | 5.2% | 5.0% | 7.6% | 7.1% | 7.0% | 6.9% | 7.0% | 7.0% | 7.2% | 6.1% | |
| ROE | 21.4% | 17.8% | 11.9% | 11.2% | 16.0% | 16.0% | 15.0% | 15.0% | 15.8% | 16.0% | 17.0% | 15.6% | |
| ROIC | 12.7% | 11.7% | 8.1% | 7.1% | 10.1% | 10.2% | 10.0% | 9.7% | 9.6% | 9.6% | 10.7% | 9.9% |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | 1.4 | 1.3 | 1.1 | 1.3 | 1.2 | 1.3 | 1.0 | 1.3 | 1.6 | 1.4 | |
| Quick Ratio | 0.8 | 1.0 | 1.2 | 1.1 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | |
| Interest Coverage | 12.8 | 9.0 | 5.7 | 7.9 | 16.3 | 12.8 | 7.5 | 7.6 | 8.8 | 10.2 | 11.1 | 8.0 |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | |
| Receivables Turnover | 7.3 | 7.2 | 6.7 | 7.1 | 7.3 | 7.0 | 7.4 | 7.2 | 7.1 | 7.1 | 7.0 | 6.7 |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $269.38 | $233.12 | $203.66 | $181.48 | $151.06 | $135.05 | $127.79 | $114.90 | $108.07 | $99.27 | $89.81 | $80.22 | |
| Cash Flow / Share | $28.92 | $30.45 | $18.08 | $13.49 | $10.56 | $27.58 | $16.16 | $14.30 | $12.28 | $13.10 | $10.14 | $10.30 | |
| Dividend Paid / Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | · | $0.60 | $0.40 | · | · | · | $0.30 | |
| EPS (TTM) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.0% | 7.8% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 37.3% | 64.4% | 11.9% | -22.7% | 7.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.2% | 12.5% | -2.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.4% | 59.1% | 6.2% | -31.9% | 5.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 30.1% | 4.8% | -8.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 24.2% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Net Income TTM | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| P/E | 9.4 | 10.7 | 14.9 | 15.4 | 11.0 | 12.5 | 15.7 | 14.0 | 14.5 | 14.9 | 17.7 | 20.5 | |
| Earnings Yield | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% | 5.7% | 4.9% | |
| Payout Ratio | 3.4% | 4.7% | 7.7% | 8.6% | 6.7% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% | 5.8% | 5.4% | |
| Annual Payout | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B | $3.55B | $3.47B | $3.45B | $3.34B | |
| Operating Expenses | $4.12B | $3.99B | $3.97B | $3.97B | $3.78B | $3.64B | $3.64B | $3.58B | $3.47B | $3.45B | $3.37B | $3.28B | $3.27B | $3.19B | $3.19B | $3.06B | |
| Operating Income | $517M | $503M | $517M | $522M | $500M | $455M | $472M | $384M | $436M | $389M | $331M | $285M | $280M | $279M | $261M | $276M | |
| Interest Expense | $40M | $37M | $42M | $38M | $35M | $40M | $40M | $45M | $49M | $53M | $54M | $53M | $49M | $51M | $44M | $36M | |
| Other Non-op | $2M | $3M | $106M | $14M | $8M | $6M | $6M | $2M | $-5M | $150.0K | $4M | $-11M | $-7M | $-14M | $5M | $-6M | |
| Pretax Income | $479M | $469M | $581M | $497M | $473M | $420M | $438M | $342M | $382M | $336M | $281M | $221M | $225M | $214M | $222M | $234M | |
| Income Tax | $115M | $110M | $134M | $118M | $111M | $99M | $101M | $76M | $88M | $70M | $62M | $52M | $55M | $52M | $52M | $57M | |
| Net Income | $358M | $349M | $446M | $373M | $353M | $317M | $332M | $259M | $289M | $262M | $216M | $167M | $171M | $163M | $175M | $183M | |
| EPS (Basic) | $6.01 | $5.71 | $7.14 | $5.92 | $5.49 | $4.87 | $5.05 | $3.89 | $4.32 | $3.90 | $3.18 | $2.42 | $2.44 | $2.31 | $2.44 | $2.52 | |
| EPS (Diluted) | $5.98 | $5.65 | $7.01 | $5.86 | $5.43 | $4.80 | $4.94 | $3.80 | $4.26 | $3.82 | $3.13 | $2.40 | $2.42 | $2.28 | $2.42 | $2.50 | |
| Shares (Basic) | 59,657,000 | 61,071,000 | · | 62,974,000 | 64,356,000 | 64,970,000 | · | 66,537,000 | 66,878,000 | 67,204,000 | · | 68,867,000 | 70,073,000 | 70,535,000 | · | 72,595,000 | |
| Shares (Diluted) | 59,910,000 | 61,668,000 | · | 63,663,000 | 64,991,000 | 66,037,000 | · | 68,108,000 | 67,920,000 | 68,482,000 | · | 69,624,000 | 70,839,000 | 71,487,000 | · | 73,060,000 | |
| EBITDA | $517M | $503M | · | $522M | $500M | $455M | · | $384M | $436M | $389M | · | $285M | $280M | $279M | · | $276M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $119M | $138M | $113M | $138M | $127M | $126M | $106M | $129M | $112M | $119M | $81M | $79M | $110M | $103M | $75M | |
| Receivables | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | · | $2.23B | $2.10B | $2.03B | · | $1.90B | |
| Other Current Assets | $505M | $406M | $436M | $333M | $327M | $317M | $292M | $262M | $236M | $243M | · | $223M | $226M | $201M | · | $262M | |
| Current Assets | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | · | $2.75B | $2.62B | $2.56B | · | $2.46B | |
| PP&E (Net) | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B | $6.44B | $6.33B | $6.18B | · | $6.09B | $6.03B | $5.95B | · | $5.94B | |
| PP&E (Gross) | $13.83B | $13.61B | · | $13.45B | $13.24B | $12.91B | · | $12.45B | $12.24B | $11.96B | · | $11.61B | $11.44B | $11.25B | · | $11.10B | |
| Accum. Depreciation | $6.69B | $6.55B | $6.48B | $6.48B | $6.35B | $6.21B | $6.07B | $6.01B | $5.91B | $5.77B | · | $5.52B | $5.41B | $5.30B | · | $5.17B | |
| Goodwill | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B | $3.97B | $3.94B | $3.93B | $3.93B | $3.91B | $3.93B | $3.91B | $3.91B | $3.87B | |
| Intangibles | · | · | $76M | · | · | · | $76M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $5.11B | · | · | · | $5.08B | · | · | · | · | · | · | · | · | · | |
| Total Assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B | |
| Accounts Payable | · | · | $750M | · | · | · | $632M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | · | $1.99B | $2.04B | $1.86B | · | $1.94B | |
| Capital Leases | $339M | $345M | $341M | $346M | $352M | $369M | $376M | $378M | $380M | $374M | · | $389M | $388M | $396M | · | $393M | |
| Deferred Tax | $3M | $3M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $560M | $533M | $528M | $590M | $629M | $682M | $656M | $660M | $570M | $551M | · | $588M | $571M | $532M | · | $500M | |
| Long-term Debt | $4.90B | $4.70B | $4.75B | $4.70B | $4.60B | $4.60B | $4.50B | $4.70B | $4.50B | $4.90B | · | $4.90B | $4.70B | $4.80B | · | $4.70B | |
| Total Debt | $4.85B | $4.71B | · | $4.69B | $4.58B | $4.65B | · | $4.66B | $4.54B | $4.86B | · | $4.92B | $4.72B | $4.80B | · | $4.70B | |
| Retained Earnings | · | · | $7.99B | · | · | · | $7.37B | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $48M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | · | $6.06B | $6.09B | $6.01B | · | $5.86B | |
| Liabilities + Equity | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $155M | $163M | $155M | $152M | $148M | $147M | $150M | $147M | $141M | $145M | $137M | $144M | $142M | $148M | $146M | |
| Stock-based Comp | $23M | $23M | $25M | $25M | $24M | $22M | $27M | $27M | $27M | $20M | $22M | $23M | $22M | $21M | $23M | $21M | |
| Operating Cash Flow | $443M | $402M | $575M | $381M | $549M | $360M | $658M | $333M | $679M | $396M | $452M | $162M | $363M | $291M | $297M | $221M | |
| CapEx | $228M | $217M | $281M | $229M | $266M | $239M | $246M | $248M | $241M | $209M | $206M | $200M | $168M | $169M | $164M | $162M | |
| Investing Cash Flow | $-234M | $-198M | $-224M | $-269M | $-306M | $-271M | $-208M | $-266M | $-243M | $-195M | $-239M | $-176M | $-170M | $-178M | $-248M | $-73M | |
| Net Debt Issued | · | $-45M | · | · | · | $-9M | · | · | · | $-64M | · | · | · | $-16M | · | · | |
| Stock Issued | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Stock Repurchased | $321M | $164M | $352M | $237M | $155M | $223M | $250M | $183M | $96M | $142M | $162M | $176M | $125M | $85M | $110M | $158M | |
| Net Stock Activity | · | $-160M | · | · | · | $-220M | · | · | · | $-139M | · | · | · | $-82M | · | · | |
| Dividends Paid | $12M | $13M | $12M | $12M | $13M | $14M | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $15M | |
| Financing Cash Flow | $-189M | $-222M | $-296M | $-135M | $-228M | $-91M | $-427M | $-90M | $-420M | $-209M | $-182M | $18M | $-224M | $-106M | $-15M | $-179M | |
| Net Change in Cash | $20M | $-19M | $55M | $-25M | $18M | $-1M | $20M | $-19M | $17M | $-8M | $34M | $1M | $-30M | $8M | $35M | $-37M | |
| Taxes Paid | $189M | $8M | $115M | $104M | $246M | $6M | $88M | $105M | $129M | $3M | $67M | $57M | $131M | $2M | $69M | $37M | |
| Free Cash Flow | · | $184M | · | · | · | $121M | · | · | · | $188M | · | · | · | $122M | · | · | |
| Levered FCF | · | $156M | · | · | · | $90M | · | · | · | $146M | · | · | · | $83M | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| Net Margin | 7.7% | 7.8% | · | 8.3% | 8.2% | 7.7% | · | 6.5% | 7.4% | 6.8% | · | 4.7% | 4.8% | 4.7% | · | 5.5% | |
| Pretax Margin | 10.3% | 10.4% | · | 11.1% | 11.1% | 10.3% | · | 8.6% | 9.8% | 8.7% | · | 6.2% | 6.3% | 6.2% | · | 7.0% | |
| EBITDA Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| ROA | 2.3% | 2.3% | · | 2.5% | 2.4% | 2.2% | · | 1.8% | 2.1% | 1.9% | · | 1.2% | 1.3% | 1.2% | · | 1.4% | |
| ROE | 4.9% | 4.9% | · | 5.4% | 5.2% | 4.9% | · | 4.1% | 4.6% | 4.3% | · | 2.8% | 2.9% | 2.8% | · | 3.0% | |
| ROIC | 3.2% | 3.2% | · | 3.4% | 3.3% | 3.0% | · | 2.7% | 3.0% | 2.8% | · | 2.0% | 1.9% | 1.9% | · | 2.0% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.0 | 1.3 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 12.9 | 13.5 | · | 13.6 | 14.1 | 11.4 | · | 8.6 | 8.9 | 7.4 | · | 5.3 | 5.7 | 5.5 | · | 7.7 |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 1.8 | 1.8 | · | 1.7 | 1.8 | 1.8 | · | 1.8 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $77.42 | $72.89 | · | $70.61 | $65.91 | $62.08 | · | $58.19 | $57.53 | $56.13 | · | $51.17 | $50.09 | $48.51 | · | $45.66 | |
| Cash Flow / Share | · | $6.51 | · | · | · | $5.45 | · | · | · | $5.79 | · | · | · | $4.07 | · | · | |
| Dividend Paid / Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $24.50 | $23.95 | · | $21.03 | $18.97 | $17.80 | · | $15.01 | $13.61 | $11.77 | · | $9.52 | $9.62 | $9.40 | · | $9.72 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.11B | $17.76B | · | $16.99B | $16.46B | $16.08B | · | $15.42B | $15.02B | $14.66B | · | $14.03B | $13.80B | $13.57B | · | $13.23B | |
| Net Income TTM | $1.53B | $1.52B | · | $1.38B | $1.26B | $1.20B | · | $1.03B | $934M | $817M | · | $676M | $692M | $685M | · | $740M | |
| P/E | 6.1 | 7.5 | · | 9.7 | 9.5 | 10.6 | · | 15.3 | 13.6 | 15.5 | · | 13.2 | 16.4 | 13.5 | · | 9.1 | |
| Earnings Yield | 16.5% | 13.4% | · | 10.3% | 10.5% | 9.5% | · | 6.6% | 7.4% | 6.5% | · | 7.6% | 6.1% | 7.4% | · | 11.0% | |
| Payout Ratio | · | 3.7% | · | · | · | 4.3% | · | · | · | 5.2% | · | · | · | 8.7% | · | · | |
| Annual Payout | $50M | $51M | · | $52M | $53M | $53M | · | $54M | $54M | $55M | · | $56M | $57M | $58M | · | $60M |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 매출 | $17.36B | $15.83B | $14.28B | · | · |
| 영업이익률 % | 11.5% | 10.6% | 8.2% | · | · |
| 순이익 | $1.49B | $1.14B | $718M | · | · |
| 희석 EPS | $23.10 | $16.82 | $10.23 | · | · |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.7 | 0.7 | 0.8 | · | · |
| 유동비율 | 1.1 | 1.3 | 1.4 | · | · |
| 당좌 비율 | 0.8 | 1.0 | 1.2 | · | · |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $849M | $1.12B | $525M | · | · |
기관 투자자 (13F) 644개의 제출자 · $9.0B 전체 · 기준일 2026년 9월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 73 (-10 이전 분기 대비) | 122 (+33 이전 분기 대비) | 215 (-37 이전 분기 대비) | 240 (+8 이전 분기 대비) | +2.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1,414,195,886 | 6,486,542 | 15.65% | 주식 |
| First Eagle Investment Management, LLC | $677,233,918 | 4,554,670 | 7.49% | 주식 |
| BlackRock, Inc. | $603,655,463 | 4,059,826 | 6.68% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $504,386,069 | 3,392,199 | 5.58% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $364,614,198 | 2,452,177 | 4.03% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $328,686,665 | 2,210,595 | 3.64% | 주식 |
| STATE STREET CORP | $312,637,527 | 2,102,613 | 3.46% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $293,152,556 | 1,974,065 | 3.24% | 주식 |
| PZENA INVESTMENT MANAGEMENT LLC | $292,819,232 | 1,969,327 | 3.24% | 주식 |
| Invesco Ltd. | $290,116,048 | 1,951,147 | 3.21% | 주식 |
| FMR LLC | $210,657,318 | 1,416,755 | 2.33% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $210,522,439 | 1,415,848 | 2.33% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $158,819,352 | 1,068,124 | 1.76% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $140,451,548 | 944,592 | 1.55% | 주식 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $135,479,763 | 906,103 | 1.50% | 주식 |
| NORGES BANK | $132,110,916 | 888,499 | 1.46% | 주식 |
| MORGAN STANLEY | $111,481,141 | 749,754 | 1.23% | 주식 |
| GOLDMAN SACHS GROUP INC | $89,504,438 | 601,953 | 0.99% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85,524,258 | 575,185 | 0.95% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $83,716,782 | 563,029 | 0.93% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $76,891,019 | 523,210 | 0.85% | 주식 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $75,911,300 | 510,534 | 0.84% | 주식 |
| NORTHERN TRUST CORP | $67,032,574 | 450,821 | 0.74% | 주식 |
| Invenomic Capital Management LP | $63,529,884 | 427,264 | 0.70% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $62,058,597 | 417,369 | 0.69% | 주식 |
| Qube Research & Technologies Ltd | $59,094,313 | 397,433 | 0.65% | 주식 |
| MACKENZIE FINANCIAL CORP | $56,636,764 | 380,905 | 0.63% | 주식 |
| Ranmore Fund Management Ltd | $56,501,159 | 379,993 | 0.63% | 주식 |
| Allianz Asset Management GmbH | $56,202,738 | 377,986 | 0.62% | 주식 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $52,580,501 | 353,625 | 0.58% | 주식 |
| UBS Group AG | $49,695,321 | 334,221 | 0.55% | 주식 |
| CITADEL ADVISORS LLC | $45,818,377 | 308,147 | 0.51% | 주식 |
| Quantinno Capital Management LP | $45,782,797 | 307,907 | 0.51% | 주식 |
| Bank of New York Mellon Corp | $44,605,741 | 299,992 | 0.49% | 주식 |
| NORDEA INVESTMENT MANAGEMENT AB | $44,371,846 | 300,663 | 0.49% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $44,081,678 | 296,467 | 0.49% | 주식 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42,437,187 | 237,119 | 0.47% | 주식 |
| Khrom Capital Management LLC | $39,401,958 | 264,994 | 0.44% | 주식 |
| Russell Investments Group, Ltd. | $37,642,835 | 253,289 | 0.42% | 주식 |
| Bridgewater Associates, LP | $33,919,311 | 228,121 | 0.38% | 주식 |
| SEI INVESTMENTS CO | $33,100,670 | 222,614 | 0.37% | 주식 |
| MOORE CAPITAL MANAGEMENT, LP | $33,071,927 | 222,422 | 0.37% | 주식 |
| Allspring Global Investments Holdings, LLC | $32,949,468 | 218,817 | 0.36% | 주식 |
| DEUTSCHE BANK AG\ | $31,202,151 | 209,847 | 0.35% | 주식 |
| FIRST TRUST ADVISORS LP | $31,057,609 | 208,876 | 0.34% | 주식 |
| CARRONADE CAPITAL MANAGEMENT, LP | $29,738,000 | 200,000 | 0.33% | 주식 |
| JPMORGAN CHASE & CO | $29,603,947 | 198,975 | 0.33% | 주식 |
| Arbejdsmarkedets Tillaegspension | $28,712,039 | 193,100 | 0.32% | 주식 |
| FRANKLIN RESOURCES INC | $28,049,718 | 188,646 | 0.31% | 주식 |
| BARCLAYS PLC | $27,758,340 | 186,686 | 0.31% | 주식 |
회사 내부자 24 명의 내부자 · 10 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Marc D Miller | President and CEO | 2026년 3월 26일 A | 388,621 | 0 | 0 | $0 |
| Steve Filton | Executive Vice President & CFO | 2026년 3월 26일 A | 144,715 | 0 | 0 | $0 |
| Alan B Miller | Executive Chairman | 2026년 5월 27일 J | 25,495 | 0 | 0 | $0 |
| Edward H Sim | Executive Vice President | 2026년 3월 26일 A | 24,790 | 0 | 0 | $0 |
| Matthew Jay Peterson | Executive Vice President, UHS | 2026년 3월 26일 A | 31,984 | 0 | 0 | $0 |
| Marvin G. Pember | Executive Vice President | 2022년 3월 23일 A | 36,599 | 0 | 0 | $0 |
| Debra K Osteen | Executive Vice President | 2018년 4월 13일 A | 93,174 | 0 | 0 | $0 |
| Richard C Wright | Vice President | 2012년 11월 26일 S | 0 | 0 | 0 | $0 |
| Michael Marquez | Senior Vice President | 2010년 6월 4일 M | 28,525 | 0 | 0 | $0 |
| Kevin J Gross | Senior Vice President | 2007년 5월 31일 M | 623 | 0 | 0 | $0 |
| Nina Chen-Langenmayr | 이사 | 2026년 5월 20일 A | 4,267 | 0 | 0 | $0 |
| Maria Ruderman Singer | 이사 | 2026년 5월 20일 A | 9,792 | 0 | 0 | $0 |
| Warren J. Nimetz | 이사 | 2026년 5월 20일 A | 9,698 | 0 | 2 | $-852,356 |
| Eileen C. Mcdonnell | 이사 | 2026년 5월 20일 A | 9,406 | 0 | 0 | $0 |
| Elliot J Md Mba Sussman | 이사 | 2026년 5월 20일 A | 7,330 | 0 | 3 | $-345,899 |
| Lawrence S. Gibbs | 이사 | 2023년 3월 7일 S | 2,230 | 0 | 0 | $0 |
| Robert H Hotz | 이사 | 2019년 7월 29일 M | 52,715 | 0 | 0 | $0 |
| John H Herrell | 이사 | 2018년 5월 15일 M | 19,274 | 0 | 0 | $0 |
| Anthony Pantaleoni | 이사 | 2017년 11월 29일 M | 1,794 | 0 | 0 | $0 |
| Leatrice Ducat | 이사 | 2013년 3월 5일 M | 4,000 | 0 | 0 | $0 |
| Richard J Santorum | 이사 | 2011년 5월 16일 M | 7,437 | 0 | 0 | $0 |
| Daniel B. Silvers | 이사 | 2011년 5월 3일 M | 2,048 | 0 | 0 | $0 |
| John F Williams JR | 이사 | 2008년 11월 21일 A | 3,975 | 0 | 0 | $0 |
| Robert A Meister | 이사 | 2007년 11월 21일 A | · | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 104 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2.57% | 159,598 NS | 2026년 7월 31일 | N-PORT |
| LYLD · Cambria ETF Trust | 2.14% | 922 NS | 2026년 7월 31일 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.62% | 81,159 SH | 2026년 10월 1일 | 일간 |
| CVSM · Elevation Series Trust | 1.59% | 8,938 NS | 2026년 7월 31일 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.51% | 176,878 SH | 2026년 10월 1일 | 일간 |
| IHF · iShares Trust | 1.35% | 102,351 SH | 2026년 9월 11일 | 일간 |
| RNIN · EA Series Trust | 1.29% | 13,918 NS | 2026년 7월 31일 | N-PORT |
| SYLD · Cambria ETF Trust | 1.09% | 64,307 NS | 2026년 7월 31일 | N-PORT |
| SRHQ · Elevation Series Trust | 1.04% | 13,049 NS | 2026년 7월 31일 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 0.95% | 15,263 NS | 2026년 7월 31일 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.80% | 10,896 NS | 2026년 7월 31일 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0.54% | 23,720 NS | 2026년 7월 31일 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.49% | 43,874 NS | 2026년 7월 31일 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.44% | 41,492 SH | 2026년 10월 1일 | 일간 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.42% | 34,637 NS | 2026년 7월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.40% | 345,907 NS | 2026년 7월 31일 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.31% | 29,932 SH | 2026년 10월 1일 | 일간 |
| DFSV · Dimensional ETF Trust | 0.31% | 151,188 NS | 2026년 7월 31일 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.28% | 7,534 NS | 2026년 7월 31일 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 7,517 NS | 2026년 7월 31일 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.24% | 2,408 NS | 2026년 7월 31일 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1,112,873 SH | 2026년 10월 1일 | 일간 |
| BKMC · BNY Mellon ETF Trust | 0.20% | 7,667 NS | 2026년 7월 31일 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.19% | 5,968,000 | 2026년 10월 1일 | 일간 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 22,463 NS | 2026년 7월 31일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 27,092 NS | 2026년 7월 31일 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0.18% | 107,089 NS | 2026년 7월 31일 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.16% | 737,146 SH | 2026년 8월 19일 | 일간 |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.16% | 220,000 | 2026년 10월 1일 | 일간 |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 7,588 NS | 2026년 7월 31일 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.15% | 8,469 SH | 2026년 8월 19일 | 일간 |
| IYH · iShares Trust | 0.14% | 29,765 SH | 2026년 9월 11일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 24,277 NS | 2026년 7월 31일 | N-PORT |
| SMMD · iShares Trust | 0.12% | 27,226 SH | 2026년 9월 11일 | 일간 |
| LGDX · Tidal Trust III | 0.12% | 1,016 NS | 2026년 7월 31일 | N-PORT |
| IXJ · iShares Trust | 0.12% | 28,234 SH | 2026년 9월 11일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.12% | 105,486 NS | 2026년 7월 31일 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.11% | 3,422,000 | 2026년 9월 30일 | 일간 |
| NFRA · FlexShares Trust | 0.11% | 20,262 NS | 2026년 7월 31일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.11% | 153,595 SH | 2026년 8월 19일 | 일간 |
| GLOF · iShares Trust | 0.11% | 1,247 SH | 2026년 9월 11일 | 일간 |
| CURE · Direxion Shares ETF Trust | 0.10% | 1,049 NS | 2026년 7월 31일 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 4,369 SH | 2026년 10월 1일 | 일간 |
| DXUV · Dimensional ETF Trust | 0.09% | 3,027 NS | 2026년 7월 31일 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.09% | 51,375 SH | 2026년 10월 1일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.09% | 1,161,113 SH | 2026년 8월 19일 | 일간 |
| IWS · iShares Trust | 0.09% | 75,629 SH | 2026년 9월 11일 | 일간 |
| WSML · iShares Trust | 0.08% | 3,240 SH | 2026년 9월 11일 | 일간 |
| TILT · FlexShares Trust | 0.08% | 9,796 NS | 2026년 7월 31일 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.07% | 4,075 SH | 2026년 10월 1일 | 일간 |
| RECS · Columbia ETF Trust I | 0.07% | 25,532 NS | 2026년 7월 31일 | N-PORT |
| IWR · iShares Trust | 0.06% | 208,577 SH | 2026년 9월 11일 | 일간 |
| DFUV · Dimensional ETF Trust | 0.06% | 53,251 NS | 2026년 7월 31일 | N-PORT |
| XOEF · iShares Trust | 0.05% | 67 SH | 2026년 9월 11일 | 일간 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.05% | 28,658 SH | 2026년 10월 1일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.04% | 107,516 NS | 2026년 7월 31일 | N-PORT |
| IVE · iShares Trust | 0.03% | 88,425 SH | 2026년 9월 11일 | 일간 |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 12,323 SH | 2026년 8월 19일 | 일간 |
| IUSV · iShares Trust | 0.03% | 46,100 SH | 2026년 9월 11일 | 일간 |
| DCOR · Dimensional ETF Trust | 0.03% | 5,685 NS | 2026년 7월 31일 | N-PORT |
| IWD · iShares Trust | 0.02% | 112,974 SH | 2026년 9월 11일 | 일간 |
| EGLE · Global X Funds | 0.02% | 3 NS | 2026년 7월 31일 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 30,745 SH | 2026년 8월 19일 | 일간 |
| DYNF · BlackRock ETF Trust | 0.02% | 45,056 SH | 2026년 9월 11일 | 일간 |
| TOPC · iShares Trust | 0.02% | 33 SH | 2026년 9월 11일 | 일간 |
| XVV · iShares Trust | 0.02% | 647 SH | 2026년 9월 11일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.02% | 11,778 NS | 2026년 7월 31일 | N-PORT |
| XYLG · Global X Funds | 0.02% | 58 NS | 2026년 7월 31일 | N-PORT |
| XYLD · Global X Funds | 0.02% | 2,904 NS | 2026년 7월 31일 | N-PORT |
| XRMI · Global X Funds | 0.01% | 44 NS | 2026년 7월 31일 | N-PORT |
| PTLC · Pacer Funds Trust | 0.01% | 2,808 NS | 2026년 7월 31일 | N-PORT |
| XCLR · Global X Funds | 0.01% | 3 NS | 2026년 7월 31일 | N-PORT |
| IVV · iShares Trust | 0.01% | 671,648 SH | 2026년 9월 11일 | 일간 |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 308 SH | 2026년 10월 1일 | 일간 |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 3,737 SH | 2026년 10월 1일 | 일간 |
| IWB · iShares Trust | 0.01% | 36,488 SH | 2026년 9월 11일 | 일간 |
| IYY · iShares Trust | 0.01% | 2,238 SH | 2026년 9월 11일 | 일간 |
| SPUU · Direxion Shares ETF Trust | 0.01% | 201 NS | 2026년 7월 31일 | N-PORT |
| IWV · iShares Trust | 0.01% | 14,744 SH | 2026년 9월 11일 | 일간 |
| QDPL · Pacer Funds Trust | 0.01% | 1,283 NS | 2026년 7월 31일 | N-PORT |
| ITOT · iShares Trust | 0.01% | 68,363 SH | 2026년 9월 11일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.01% | 14,968 NS | 2026년 7월 31일 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 42 SH | 2026년 10월 1일 | 일간 |
| HCMT · Direxion Shares ETF Trust | 0.01% | 369 NS | 2026년 7월 31일 | N-PORT |
| XTR · Global X Funds | 0.01% | 3 NS | 2026년 7월 31일 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 4,165 NS | 2026년 7월 31일 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 1,383,774 SH | 2026년 8월 19일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1,606,967 SH | 2026년 8월 19일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 41,234 SH | 2026년 8월 19일 | 일간 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8,402 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 4,280 SH | 2026년 8월 19일 | 일간 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 11,510 SH | 2026년 8월 19일 | 일간 |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.01% | 879 SH | 2026년 10월 1일 | 일간 |
| DFLV · Dimensional ETF Trust | 0.00% | 636 NS | 2026년 7월 31일 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 3,000 | 2026년 9월 30일 | 일간 |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 2026년 7월 15일 | 일간 |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 2026년 7월 15일 | 일간 |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 2026년 7월 15일 | 일간 |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 2026년 7월 15일 | 일간 |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 2026년 7월 30일 | 일간 |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 2026년 7월 30일 | 일간 |
| ISCB · iShares Trust | · | 2,307 SH | 2026년 9월 11일 | 일간 |
| ISCV · iShares Trust | · | 11,393 SH | 2026년 9월 11일 | 일간 |
| SMMV · iShares Trust | · | 2,436 SH | 2026년 9월 1일 | 일간 |
UHS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
17 명의 애널리스트 · 2026-09-27평균 목표 $194.35 +10.6%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.